How JULÄINE PLLA supports gradual collagen remodelling

JULÄINE Collagen Biostimulator: How It Works and What to Expect

JULÄINE is a collagen biostimulator designed for people who want gradual support for facial structure and skin quality rather than an instantly obvious change. It uses poly-L-lactic acid (PLLA), a biocompatible and biodegradable material, to encourage the skin’s own collagen-producing cells. The result is not created by a permanent implant or a large deposit of gel: it develops as your tissues respond over time.

This guide explains what JULÄINE does, how a treatment course may be planned, what recovery can look like and where the current evidence has limits. Treatment must always follow a face-to-face medical consultation; book a Dr Motox consultation if you would like an individual assessment.

What is JULÄINE?

JULÄINE is an injectable PLLA collagen biostimulator. “Biostimulator” means the product is intended to trigger a controlled biological response—in this case, signalling fibroblasts to make collagen. Fibroblasts are the skin’s repair and support cells. Collagen is one of the proteins that gives skin strength and structure, but production and organisation change with age.

The manufacturer describes JULÄINE’s LASYNPRO microspheres as uniform PLLA particles. Its stated medical indication is correction of mild to severe nasolabial folds in adults. In practice, suitability, treatment area and injection plan must remain within the product instructions and the clinician’s training. It is not a general answer to every line, hollow or skin concern.

How does JULÄINE work?

After precise placement, the PLLA particles create a local tissue response. Fibroblasts become active around the particles and gradually lay down new collagen. The PLLA then biodegrades. This process takes time, which is why the intended result should emerge progressively rather than appearing fully formed on treatment day.

Diagram explaining how JULÄINE PLLA microspheres stimulate a gradual collagen response
How PLLA treatment can lead from local tissue signalling to gradual collagen remodelling. Results vary.

Immediately after treatment, injected fluid and normal swelling can make the area look fuller. That early fullness is not the final collagen result and usually settles. The useful comparison is a scaffold being rebuilt over time, not a cushion being filled in one appointment.

Is JULÄINE a dermal filler or a skin booster?

JULÄINE is best described as a collagen biostimulator. Traditional hyaluronic-acid filler provides volume from the gel itself and can create a more immediate contour change. JULÄINE relies on gradual collagen formation, so it suits a different goal and timeline.

It is also different from treatments focused mainly on hydration. For example, Profhilo uses injectable hyaluronic acid to support hydration and skin quality, while polynucleotides are another category with different ingredients and evidence. Our Profhilo versus polynucleotides guide explains those options. No single product is automatically “best”; anatomy, concern, timescale and risk profile decide the plan.

Who may be suitable?

JULÄINE may be considered for an adult seeking gradual improvement in facial support, particularly around appropriately assessed nasolabial folds, who accepts that results are subtle and take time. It can appeal to someone who does not want an immediately volumised appearance. Good candidates also understand that natural-looking treatment depends on conservative planning, correct placement and realistic expectations.

When treatment may need to be avoided or postponed

Elective injectable treatment is usually postponed during pregnancy or breastfeeding, and when there is active infection, a cold sore, inflamed or broken skin near the treatment area, or an unresolved dental infection. Tell your clinician about allergies, autoimmune conditions, immune suppression, bleeding disorders, previous filler or biostimulator treatments and all medicines or supplements, including anticoagulants. These details do not always mean treatment is impossible, but they can change safety and timing.

How many sessions are needed?

A planned course may involve three sessions around one month apart, but that is not a universal prescription. The number of appointments, spacing, dose and placement should be personalised after examination. Some people may need a different course or may be better served by another treatment.

Timeline diagram showing consultation, treatment course, early recovery and gradual review for JULÄINE
A typical clinician-led journey. The exact schedule and maintenance plan are individual.

Changes are assessed over weeks and months, not days. Maintenance should be based on review rather than a fixed promise. Age, metabolism and baseline tissue quality all influence the response.

Downtime, risks and aftercare

Common short-term effects include redness, swelling, tenderness, bruising and temporary unevenness around injection points. Less commonly, lumps, persistent nodules, inflammation or infection may occur. As with any facial injection, rare but serious vascular complications are possible. Seek urgent advice for severe or worsening pain, pale or mottled skin, marked colour change, visual disturbance or any symptom that feels disproportionate.

Follow the aftercare instructions given for your exact treatment. Do not massage unless your injector specifically tells you to, because protocols vary. Avoid pressing or repeatedly checking the area, and ask before returning to strenuous exercise, heat exposure, alcohol or active skincare.

Once the skin is closed and calm, gentle hydration can support comfort. The Dr Motox Exosome Collagen Face & Neck Sheet Mask is a staple hydration step suitable for dry, oily and sensitive skin types. Patch test first, follow your injector’s timing advice and do not apply it over infected, broken or actively inflamed skin. See our post-treatment hydration routine for a simple barrier-conscious approach.

What does the evidence show?

The biological principle of PLLA collagen stimulation is established, but product-specific JULÄINE evidence is still developing. A 2025 prospective, multicentre study reported improvement in nasolabial-fold severity during early follow-up and mainly mild, temporary adverse events. It was preliminary, open-label, non-randomised and manufacturer-supported, so it cannot predict every patient’s response or replace a large independent controlled trial.

You can read the manufacturer’s product information and the published 2025 preliminary study. Marketing claims should always be weighed against study design, follow-up length and individual risk.

JULÄINE FAQs

When will I see results?

Some early fullness may be swelling. The intended collagen response develops gradually over several weeks and can continue across a treatment course. There is no guaranteed day on which a final result appears.

Will JULÄINE make me look overfilled?

Its gradual mechanism can support a subtle plan, but no injectable is automatically natural-looking. Assessment, dose, placement, timing and knowing when not to treat are what prevent excess.

Is there downtime?

Many people return to normal activities quickly, but swelling or bruising can remain visible for several days. Allow flexibility around important events and follow the personalised advice from your clinician.

Is JULÄINE right for me?

That can only be decided after consultation. A responsible plan considers your medical history, facial anatomy, previous treatments, goals and tolerance for gradual change before comparing JULÄINE with filler, Profhilo, polynucleotides or no treatment.

This article is educational and does not replace medical assessment. Injectable treatments carry risks and should be performed by an appropriately trained medical professional using an authorised product and an individual treatment plan.